학술논문

Digoxin use and lower risk of 30‐day all‐cause readmission in older patients with heart failure and reduced ejection fraction receiving β‐blockers

Document Type

article

Author

Lam, Phillip H; Bhyan, Poonam; Arundel, Cherinne; Dooley, Daniel J; Sheriff, Helen M; Mohammed, Selma F; Fonarow, Gregg C; Morgan, Charity J; Aronow, Wilbert S; Allman, Richard M; Waagstein, Finn; Ahmed, Ali

Source

Clinical Cardiology. 41(3)

Subject

Biomedical and Clinical Sciences
Clinical Sciences
Clinical Research
Aging
Cardiovascular
Good Health and Well Being
Adrenergic beta-Antagonists
Aged
Alabama
Cardiotonic Agents
Digoxin
Dose-Response Relationship
Drug
Drug Therapy
Combination
Echocardiography
Female
Follow-Up Studies
Heart Failure
Heart Ventricles
Hospital Mortality
Humans
Male
Patient Readmission
Propensity Score
Retrospective Studies
Survival Rate
Time Factors
Ventricular Function
Left
Hospital Readmission
-Blockers
β-Blockers
Cardiorespiratory Medicine and Haematology
Cardiovascular System & Hematology
Cardiovascular medicine and haematology

Language

Abstract

BackgroundDigoxin use has been associated with a lower risk of 30-day all-cause admission and readmission in patients with heart failure and reduced ejection fraction (HFrEF).HypothesisDigoxin use will be associated with improved outcomes in patients with HFrEF receiving β-blockers.MethodsOf the 3076 hospitalized Medicare beneficiaries with HFrEF (EF

Online Access

Open Access (eScholarship) Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송